Your browser doesn't support javascript.
loading
XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies.
Baek, Han Bit; Lombard, Alan P; Libertini, Stephen J; Fernandez-Rubio, Aleida; Vinall, Ruth; Gandour-Edwards, Regina; Nakagawa, Rachel; Vidallo, Kathleen; Nishida, Kristine; Siddiqui, Salma; Wettersten, Hiromi; Landesman, Yosef; Weiss, Robert H; Ghosh, Paramita M; Mudryj, Maria.
Afiliación
  • Baek HB; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.
  • Lombard AP; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Libertini SJ; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.
  • Fernandez-Rubio A; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Vinall R; Biochemistry, Molecular, Cellular, and Developmental Biology Graduate Group and Biotechnology Program, University of California Davis, Davis, CA, USA.
  • Gandour-Edwards R; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.
  • Nakagawa R; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Vidallo K; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Nishida K; California Northstate College of Pharmacy, Elk Grove, CA, USA.
  • Siddiqui S; Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA, USA.
  • Wettersten H; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Landesman Y; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Weiss RH; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Ghosh PM; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.
  • Mudryj M; Department of Internal Medicine, University of California Davis, Davis, CA, USA.
Oncotarget ; 9(77): 34567-34581, 2018 Oct 02.
Article en En | MEDLINE | ID: mdl-30349650
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos